08:42 IST
NSE
Management Change
Gland Pharma Management Change
Gland Pharma Limited has appointed Mr. Deepak Sapra as the new Chief Executive Officer, effective from November 16, 2026.
Gland Pharma Ltd
Gland Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,150.60
- Market cap
- ₹51,988 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 46.1×Sector 47.3×
- Promoter holding
- 51.77%-0.06% QoQ
- FII holding
- 8.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 3Earnings Call 3Business Update 3Annual General Meeting 3Other Announcement 2Management Change 2Employee Stock Options 2Results Update 1Promoter Selling 1Product Launch 1New Order Win 1Merger & Restructuring 1Financial Results 1Capital Structure Change 1Capacity Expansion 1Board Meeting Date 1Acquisition 1
Time
2 announcements with these filters
22:46 IST
NSE
Management Change
Gland Pharma Management Change
Gland Pharma shareholders approved the reappointment of Udo Jahannes Vetter and the appointment of William Robert Keller as Independent Directors for five-year terms.